HOME >> BIOLOGY >> NEWS
Health of normal synapses seen to depend on neurotrophin signaling

In a new study, researchers at the University of Pennsylvania Medical Center have shown that the long-term health of synapses -- the connections between brain cells -- depends on ongoing signaling by a family of compounds called neurotrophins. Although neurotrophins are known to be critical during development, the current findings are among the first to show the importance of neurotrophin signaling at adult synapses. A report of the study appears in the November 24 issue of Neuron.

The results have implications for understanding how synapses are maintained in development and in adulthood, and suggest that neurotrophins may protect synapses from atrophy in aging and patients with certain neuromuscular diseases or injuries. In their experiments, the scientists used a novel technique borrowed from gene therapy to block normal neurotrophin activity in a type of synapse called the neuromuscular junction. They demonstrated that the synapses of developing and adult mice fall apart in the absence of particular neurotrophins.

The results are evocative of the synaptic changes seen in aging, muscular weakness and other diseases, suggesting that artificially augmenting neurotrophin signaling might someday be used to protect against certain kinds of synaptic failure.

"In aging animals and in aging humans, the synapse we studied -- the neuromuscular junction -- falls apart over time in much the same way it did in our neurotrophin experiments," says Rita J. Balice-Gordon, Ph.D., an assistant professor of neuroscience and senior author on the study. "Below a certain threshold, neurotrophin-deprived synapses begin to lose function. This nerve-signaling failure is one reason for the decrease in muscle strength in old age. So, one question we'll be looking at in the future is whether neurotrophin treatment of aging synapses might slow this process down." "What we've done argues that, in any disease or injury where the neuromuscular junction or other synapse is
'"/>

Contact: Sue Montgomery
smontgom@mail.med.upenn.edu
215-349-5657
University of Pennsylvania School of Medicine
22-Nov-1999


Page: 1 2

Related biology news :

1. Health of worlds sea lions the focus of Wakefield Symposium
2. OneWorld Health compiles comprehensive state of infectious diarrhea treatments, potential solutions
3. Institute for OneWorld Health nominated for the 2004 World Technology Awards
4. Healthy fats and oils essential to satisfy calorie-conscious consumers
5. Institute for OneWorld Health receives Gates Foundation grant
6. Donaghue Womens Health Investigator Program awards grants to three at Yale
7. OneWorld Health CEO outlines mutually beneficial collaborations between industry, nonprofits at BIO
8. Addressing the Healthcare Needs of Our Aging Population with Technology
9. Institute for OneWorld Health CEO to speak at BIO on leveraging opportunities for global health
10. OneWorld Health completes enrollment, treatment in Phase III India trial
11. Institute for OneWorld Health CEO advocates focus first on developing world markets

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/8/2019)... (PRWEB) , ... January 07, 2019 , ... ... and compliance solutions, is proud to welcome Thomas Kennedy as head of sales ... Miglicco, CEO for PureWay. , Mr. Kennedy has previously worked for Johnson & ...
(Date:1/7/2019)... ... January 07, 2019 , ... Franz Inc. , ... technology for Knowledge Graphs solutions, announced that it was recognized by Database ... DBTA’s data and information management recognition list includes newer approaches leveraging artificial intelligence, ...
(Date:1/4/2019)... (PRWEB) , ... January 03, 2019 , ... ... adopt 3D cell culture models into their drug discovery research workflows with biology ... improve the in vivo relevancy of in vitro studies, they create several challenges ...
Breaking Biology News(10 mins):
(Date:12/20/2018)... Colo. (PRWEB) , ... December 20, 2018 , ... New ... 2019, with major changes in regulations in the European Union (EU) on the horizon, ... companies to consider. , “The transition to the EU Medical Device Regulation (MDR), digital ...
(Date:12/19/2018)... ... December 19, 2018 , ... ... the validated release of Limfinity® version 7.1. The new release enhances the latest ... RURO as 2018 comes to an end. , Validation protocols, and their execution, ...
(Date:12/18/2018)... ... December 18, 2018 , ... USDM ... for the life sciences industry, unveiled a completely redesigned website at http://www.usdm.com ... user-friendly browsing experience for their valued clients and business partners. , The ...
(Date:12/14/2018)... ... December 14, 2018 , ... NOVA OCULUS PARTNERS, LLC, ... green light to immediately begin a clinical patient trial in Edmonton using their ... of Health Canada has granted what is called an Investigational Testing Authorization for ...
Breaking Biology Technology:
Cached News: